SEC Form 4
Nutex Health Inc. (NUTX) insider trading
In the 12 months to Oct 26, 2026, one NUTX insider reported open-market sales of $43.5K across 1 filing; 5 insiders bought $148.2K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $43.5K
- 1 filing · 1 insider
- Open-market purchases
- $148.2K
- 5 filings
Who traded NUTX, and when
- Purchase
- Sale
NUTX daily close from Oct 27, 2025 to Oct 26, 2026, between $87.01 and $225.00, last $209.01. 1 sale and 5 purchase filings by 6 insiders, marked at their filing dates. Jon Christian Bates, Chief Financial Officer: bought $102.5K across 1 filing, first filed Nov 28, 2025, last Nov 28, 2025. Scott J. Saunders, Director: sold $43.5K across 1 filing, first filed Sep 18, 2026, last Sep 18, 2026. Warren Hosseinion, President: bought $23.7K across 1 filing, first filed Mar 23, 2026, last Mar 23, 2026. Frank E. Jaumot, Director: bought $14.0K across 1 filing, first filed Mar 23, 2026, last Mar 23, 2026. Pamela W. Montgomery, Chief Legal Officer-Healthcare: bought $7.0K across 1 filing, first filed Mar 16, 2026, last Mar 16, 2026. Kelvin Spears, Director: bought $945 across 1 filing, first filed Mar 18, 2026, last Mar 18, 2026.
Largest mark · tap a row for others
Jon Christian Bates · Chief Financial Officer
Purchase $102,532
750 shares at $136.71 avg
Filed Nov 28, 2025 · traded Nov 25
Close on filing date $115.11
Jon Christian Bates · Chief Financial Officer
Chief Financial Officer
$102.5K boughtScott J. Saunders · Director
Director
$43.5K soldWarren Hosseinion · President
President
$23.7K boughtFrank E. Jaumot · Director
Director
$14.0K boughtPamela W. Montgomery · Chief Legal Officer-Healthcare
Chief Legal Officer-Healthcare
$7.0K boughtKelvin Spears · Director
Director
$945 boughtOpen-market trades
6 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Jon Christian Bates | Chief Financial Officer | — | $102.5K | 1 | — | |
| Scott J. Saunders | Director | $43.5K | — | 1 | — | |
| Warren Hosseinion | President | — | $23.7K | 1 | — | |
| Frank E. Jaumot | Director | — | $14.0K | 1 | — | |
| Pamela W. Montgomery | Chief Legal Officer-Healthcare | — | $7.0K | 1 | — | |
| Kelvin Spears | Director | — | $945 | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Scott J. Saunders Director | Sale | 203 | $214.25 | $43.5K | 400 | |
traded | Frank E. Jaumot Director | Purchase | 150 | $93.56 | $14.0K | 150 | |
traded | Warren Hosseinion President | Purchase | 252 | $94.07 | $23.7K | 7,765 | |
traded | Kelvin Spears Director | Purchase | 10 | $94.46 | $945 | 32,137 | |
traded | Pamela W. Montgomery Chief Legal Officer-Healthcare | Purchase | 79 | $88.87 | $7.0K | 2,758 | |
traded | Jon Christian Bates Chief Financial Officer | Purchase | 750 | $136.71 | $102.5K | 5,638 |
GET /stocks/filings/vX/form-4?tickers=NUTX&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"NUTX"
],
"issuer_cik": "0001479681",
"owner_cik": "0002018971",
"accession_number": "0002018971-26-000004",
"form_type": "4",
"filing_date": "2026-09-18",
"period_of_report": "2026-09-18",
"issuer_name": "Nutex Health Inc.",
"issuer_trading_symbol": "NUTX",
"owner_name": "Saunders Scott J",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-18",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 203,
"transaction_price_per_share": 214.25,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 400,
"transaction_value": 43492.75,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"NUTX"
],
"issuer_cik": "0001479681",
"owner_cik": "0001438327",
"accession_number": "0001438327-26-000002",
"form_type": "4",
"filing_date": "2026-03-23",
"period_of_report": "2026-03-19",
"issuer_name": "Nutex Health Inc.",
"issuer_trading_symbol": "NUTX",
"owner_name": "Hosseinion Warren",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "President",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-03-19",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 252,
"transaction_price_per_share": 94.0723,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 7765,
"transaction_value": 23706.2196,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 20 records
- Option exercises11 records
- Tax withholding6 records
- Other3 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Nutex Health Inc.'s CEO sold stock?
No. Thomas T. Vo (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is NUTX’s insider data?
These are NUTX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track NUTX insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for NUTX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.